Search research articles
Contact Us
Filters
Showing results (41-50 of 109) with videos related to
Page
of 11
Sort By:
ESMO Open
|
January 28, 2026
Clinical management of common toxicities with inhibitors targeting the PI3K/AKT/mTOR pathway in breast cancer
K L Jhaveri, N M Iyengar, N C Turner, et al.
Geburtshilfe Und Frauenheilkunde
|
December 8, 2015
Full Field Digital Mammography (FFDM) versus CMOS Technology versus Tomosynthesis (DBT) - Which System Increases the Quality of Intraoperative Imaging?
R Schulz-Wendtland, G Dilbat, M Bani, et al.
Breast (Edinburgh, Scotland)
|
August 25, 2011
Higher efficacy of letrozole in combination with trastuzumab compared to letrozole monotherapy as first-line treatment in patients with HER2-positive, hormone-receptor-positive metastatic breast cancer - results of the eLEcTRA trial
J Huober, P A Fasching, M Barsoum, et al.
Geburtshilfe Und Frauenheilkunde
|
April 29, 2014
Mammographic Density and Prediction of Nodal Status in Breast Cancer Patients
C C Hack, L Häberle, K Geisler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 18, 2023
Significantly longer time to deterioration of quality of life due to CANKADO PRO-React eHealth support in HR+ HER2- metastatic breast cancer patients receiving palbociclib and endocrine therapy: primary outcome analysis of the multicenter randomized AGO-B WSG PreCycle trial
N Harbeck, P A Fasching, R Wuerstlein, et al.
Der Pathologe
|
November 9, 2018
[TILGen study-immunological targets in patients with breast cancer : Influence of tumor-infiltrating lymphocytes]
R Erber, A Hartmann, M W Beckmann, et al.
Geburtshilfe Und Frauenheilkunde
|
September 16, 2014
Time and Resources Needed to Document Patients with Breast Cancer from Primary Diagnosis to Follow-up - Results of a Single-center Study
M P Lux, C S Sell, P A Fasching, et al.
Geburtshilfe Und Frauenheilkunde
|
May 31, 2016
Toxicity Assessment of a Phase III Study Evaluating FEC-Doc and FEC-Doc Combined with Gemcitabine as an Adjuvant Treatment for High-Risk Early Breast Cancer: the SUCCESS-A Trial
L Schröder, B Rack, H Sommer, et al.
Geburtshilfe Und Frauenheilkunde
|
March 24, 2017
Evaluation of a Marker Clip System in Sonographically Guided Core Needle Biopsy for Breast Cancer Localization Before and After Neoadjuvant Chemotherapy
R Schulz-Wendtland, P Dankerl, M R Bani, et al.
Geburtshilfe Und Frauenheilkunde
|
April 29, 2014
Evaluation of Newly Adapted Clip Marker System in Ultrasound-Guided Core Needle Biopsy for Suspicion of Breast Cancer
R Schulz-Wendtland, P Dankerl, G Dilbat, et al.
Page
of 11
Search research articles
Search
Showing results (41-50 of 109) with videos related to
Sort By:
Page
of 11
ESMO Open
|
January 28, 2026
Clinical management of common toxicities with inhibitors targeting the PI3K/AKT/mTOR pathway in breast cancer
K L Jhaveri, N M Iyengar, N C Turner, et al.
Geburtshilfe Und Frauenheilkunde
|
December 8, 2015
Full Field Digital Mammography (FFDM) versus CMOS Technology versus Tomosynthesis (DBT) - Which System Increases the Quality of Intraoperative Imaging?
R Schulz-Wendtland, G Dilbat, M Bani, et al.
Breast (Edinburgh, Scotland)
|
August 25, 2011
Higher efficacy of letrozole in combination with trastuzumab compared to letrozole monotherapy as first-line treatment in patients with HER2-positive, hormone-receptor-positive metastatic breast cancer - results of the eLEcTRA trial
J Huober, P A Fasching, M Barsoum, et al.
Geburtshilfe Und Frauenheilkunde
|
April 29, 2014
Mammographic Density and Prediction of Nodal Status in Breast Cancer Patients
C C Hack, L Häberle, K Geisler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 18, 2023
Significantly longer time to deterioration of quality of life due to CANKADO PRO-React eHealth support in HR+ HER2- metastatic breast cancer patients receiving palbociclib and endocrine therapy: primary outcome analysis of the multicenter randomized AGO-B WSG PreCycle trial
N Harbeck, P A Fasching, R Wuerstlein, et al.
Der Pathologe
|
November 9, 2018
[TILGen study-immunological targets in patients with breast cancer : Influence of tumor-infiltrating lymphocytes]
R Erber, A Hartmann, M W Beckmann, et al.
Geburtshilfe Und Frauenheilkunde
|
September 16, 2014
Time and Resources Needed to Document Patients with Breast Cancer from Primary Diagnosis to Follow-up - Results of a Single-center Study
M P Lux, C S Sell, P A Fasching, et al.
Geburtshilfe Und Frauenheilkunde
|
May 31, 2016
Toxicity Assessment of a Phase III Study Evaluating FEC-Doc and FEC-Doc Combined with Gemcitabine as an Adjuvant Treatment for High-Risk Early Breast Cancer: the SUCCESS-A Trial
L Schröder, B Rack, H Sommer, et al.
Geburtshilfe Und Frauenheilkunde
|
March 24, 2017
Evaluation of a Marker Clip System in Sonographically Guided Core Needle Biopsy for Breast Cancer Localization Before and After Neoadjuvant Chemotherapy
R Schulz-Wendtland, P Dankerl, M R Bani, et al.
Geburtshilfe Und Frauenheilkunde
|
April 29, 2014
Evaluation of Newly Adapted Clip Marker System in Ultrasound-Guided Core Needle Biopsy for Suspicion of Breast Cancer
R Schulz-Wendtland, P Dankerl, G Dilbat, et al.
Page
of 11